Sickle Cell Disease Diagnosis Market Analysis, Development, and Forecast by 2031

MARKET INTRODUCTION

Sickle cell disease is an inherited red blood cell disorder in which healthy red blood cells aren't enough to carry oxygen to all parts of the body. In this condition the red blood cells are sickles or crescent moons shape. Blood test is the most common type of diagnostic technique to detect sickle cell anemia. In the US, sickle cell disease blood test is part of routine newborn screening.

MARKET DYNAMICS

The key factors driving the growth of the sickle cell disease diagnosis market are increasing prevalence of sickle cell disease, increasing R&D activities to develop novel therapeutics, and newborn screening programs. However, lack of awareness about this disease and unavailability of diagnosis options in rural areas is likely to hamper the market growth during the forecast period.

MARKET SCOPE

The "Sickle Cell Disease Diagnosis Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of sickle cell disease diagnosis market with detailed market segmentation by technology, age group and end user. The sickle cell disease diagnosis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in sickle cell disease diagnosis market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The sickle cell disease diagnosis market is segmented on the basis of technology, age group and end user. Based on technology, the market is segmented as hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), point-of-care tests, other tests. The age group market is segmented into newborn screening (12 months and below), adult screening (25 to 60 years), and other age groups (1 to 25 and above 60 years). On the basis of end user, the market is categorized as government labs, private labs, corporate labs, PPP (Public-Private-Partnerships).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the sickle cell disease diagnosis market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sickle cell disease diagnosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting sickle cell disease diagnosis market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sickle cell disease diagnosis market in these regions.

MARKET PLAYERS

The report covers key developments in the sickle cell disease diagnosis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from sickle cell disease diagnosis market are anticipated to have lucrative growth opportunities in the future with the rising demand for sickle cell disease diagnosis in the global market. Below mentioned is the list of few companies engaged in the sickle cell disease diagnosis market.

The report also includes the profiles of key players in sickle cell disease diagnosis market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

1. STRECK
2. BIOMEDOMICS INC.
3. Hemex Health
4. Silver Lake Research Corporation
5. Laboratory Corporation of America Holdings
6. Quest Diagnostics Incorporated
7. HALCYON BIOMEDICAL INCORPORATED
8. PerkinElmer Inc.
9. Bio-Rad Laboratories, Inc.
10. Daktari Diagnostics

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Sickle Cell Disease Diagnosis Report Scope